Faithward Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Faithward Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Buy	42,512 +37,688	+781%	+$2.2M	1.56%	13
2025 Q4	$260K	Buy	4,824 +15	+0.3%	+$722	0.04%	284
2025 Q3	$217K	Sell	4,809 -553	-10%	-$25.8K	0.03%	289
2025 Q2	$248K	Buy	5,362 +507	+10%	+$24.9K	0.04%	239
2025 Q1	$296K	Buy	4,855 +349	+8%	+$20.3K	0.05%	211
2024 Q4	$255K	Sell	4,506 -303	-6%	-$16.9K	0.04%	216
2024 Q3	$249K	Buy	+4,809	New	+$226K	0.04%	238
2024 Q2	–	Sell	-4,894	Closed	-$265K	–	254
2024 Q1	$265K	Buy	+4,894	New	+$249K	0.05%	214
2023 Q2	–	Sell	-4,373	Closed	-$302K	–	274
2023 Q1	$302K	Buy	+4,373	New	+$308K	0.07%	146
2020 Q2	–	Sell	-4,348	Closed	-$242K	–	215
2020 Q1	$242K	Sell	4,348 -40	-0.9%	-$2.44K	0.07%	140
2019 Q4	$282K	Buy	+4,388	New	+$251K	0.07%	137

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Faithward Advisors's BMY Position: Q1 2026 in Review

Faithward Advisors increased its Bristol-Myers Squibb (BMY) stake by 781% in Q1 2026, buying an estimated $2.2M and bringing the position to 42,512 shares worth $10.9M. The position accounts for 1.56% of the portfolio, ranked #13.

Faithward Advisors first reported a position in BMY in Q4 2019 and has held it in 11 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Faithward Advisors held 42,512 shares of Bristol-Myers Squibb worth $10.9M as of Q1 2026.
Faithward Advisors bought 37,688 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.2M.
Bristol-Myers Squibb made up 1.56% of Faithward Advisors's portfolio in Q1 2026, its #13 holding.
Faithward Advisors first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 11 quarters since.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Faithward Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.